Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-019 - Immune Cell Infiltrates in Non-Small Cell Lung Cancer and Interleukin-22 Expression
09:30 - 09:30 | Presenter: Rudolf M Huber | Author(s): J. Stump, S. Reu, C. Ballesteros-Merino, C. Karches, J.S. Gosálvez, A. Tufman, S. Kobold, J. Neumann, Z. Feng, R. Hatz, R.E. Sanborn, John R Handy, B.A. Fox, C.B. Bifulco, H. Winter
- Abstract
Loading...
-
+
P2.13 - Radiology/Staging/Screening
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiology/Staging/Screening
-
+
P2.13-009 - Results of Low-Dose CT Lung Cancer Screening at a Non-University Tertiary Hospital System in Oregon, USA
09:30 - 09:30 | Presenter: John R Handy | Author(s): M.D. Skokan, E. Rauch, S. Zinck, R.E. Sanborn, C. Betzer
- Abstract
Loading...
-
+
MA 10 - Immunotherapy I
- 11:00 - 12:30
- 10/17/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:S. Wang, Robert Pirker
-
+
MA 10.05 - Improved Outcome for Immune Checkpoint Inhibitors (ICI) in Patients Previously Treated with Bavituximab in the SUNRISE Trial
11:30 - 11:35 | Presenter: Michael Boyer | Author(s): David R Spigel, P. Mainwaring, H. Lena, M. McCleod, G. Losonczy, R.E. Sanborn, R. Natale, M. Tang, J. Lai, N.L. Kallinteris, Joseph Shan, David E Gerber
- Abstract
Loading...
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.02 - Response to Ensartinib in TKI Naïve ALK+ NSCLC Patients
15:50 - 15:55 | Presenter: Heather A Wakelee | Author(s): R.E. Sanborn, Jorge Nieva, S.N. Waqar, C. Brzezniak, J. Bauman, Joel W. Neal, G. Dukart, F. Tan, K. Harrow, C. Liang, L. Horn
- Abstract
Loading...